NEWSROOM

An online resource for members of the media and the investment community.

SUBSCRIBE TO EMAIL ALERTS

Articles
Jan 17, 2022

By Joye Bramble PhD, Exton Site Head and Vice President, Biopharmaceutical Development at Eisai US Our scientific understanding of cancer has undergone a significant transformation over the last...


Fact Sheet

Learn more about key information and milestones.

Stay up to date with the latest from Eisai with email alerts

Sign up for Alerts
* Required Fields
Contact

For media inquiries, please contact: 

Corporate
Patricia Councill
Director, Corporate Communications
201-746-2139
Patricia_Councill@eisai.com

Neurology
Libby Holman
Director, Product Communications
201-753-1945
Libby_Holman@eisai.com

Oncology
Michele Randazzo
Director, Product Communications
201-746-2979
Michele_Randazzo@eisai.com